StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study

NCT02679664 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

312

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Rosuvastatin

Sponsor

Ottawa Hospital Research Institute